- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ASP8062 Placebo
Total 53765 results
-
Astellas Pharma Europe B.V.CompletedUnderactive BladderJapan, Poland, Germany, Netherlands, Slovakia, United Kingdom
-
Astellas Pharma IncCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.CompletedTolerability | Safety | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes | Chronic Kidney DiseaseSpain, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
SanofiCompletedSarcomaBelgium, Hungary, United States, Brazil, France, India, Italy, Serbia, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruiting
-
Astellas Pharma IncCompletedSolid Tumor | B-Cell Lymphoma | Advanced Malignancies | Positive for Anaplastic Lymphoma Kinase | Positive for Proto-Oncogene Tyrosine-Protein Kinase ROSUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma Global Development, Inc.Completed
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
Astellas Pharma Global Development, Inc.National Institute on Drug Abuse (NIDA)Completed
-
Astellas Pharma Global Development, Inc.Withdrawn
-
Astellas Pharma IncCompleted
-
Astellas Pharma Global Development, Inc.RecruitingB-cell LymphomaAustralia
-
Astellas Pharma Global Development, Inc.CompletedFibromyalgiaUnited States
-
SanofiCompleted
-
SanofiCompletedNeoplasmsFrance, Italy, Switzerland
-
Astellas Pharma Global Development, Inc.National Institute on Drug Abuse (NIDA)Completed
-
SanofiCompleted
-
National Institute on Alcohol Abuse and Alcoholism...Astellas Pharma IncCompletedAlcohol Drinking | Alcohol Use Disorder | Alcohol Use Disorder (AUD)United States
-
Astellas Pharma Global Development, Inc.TerminatedPainful Diabetic Peripheral Neuropathy (PDPN)United States
-
SanofiCompleted
-
Astellas Pharma Europe B.V.CompletedDiabetes Mellitus | Diabetic Macular EdemaUnited States
-
SanofiCompletedOvarian Cancer RecurrentBelgium, Russian Federation, Poland, Spain, Czech Republic, United States, France, Germany, Italy, Ukraine
-
Astellas Pharma IncRecruiting
-
Astellas Pharma Global Development, Inc.Recruiting
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompleted
-
Astellas Pharma Europe B.V.CompletedOsteoarthritis of the Knee | Chronic Lower Back PainBelgium, Czechia, Germany, Hungary, Spain, United Kingdom
-
SanofiCompletedNeoplasms, MalignantFrance, United Kingdom, Italy
-
Ege UniversityCompletedSleep | AnxietyTurkey
-
Assistance Publique - Hôpitaux de ParisIltoo PharmaCompleted
-
Washington University School of MedicineCompleted
-
Orphan AustraliaCompleted
-
Nowarta Biopharma IncCompletedPlantar WartsUnited States
-
Chinese University of Hong KongRecruiting
-
National University of MalaysiaMalaysia Palm Oil BoardUnknownCardiovascular Diseases | Hypercholesterolemia | HyperlipidemiasMalaysia
-
University of South CarolinaU.S. Army Medical Research and Development CommandCompletedSeaweed Associated Changes in Healthy SubjectsUnited States
-
Gladwin, Mark, MDNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedSedentary Lifestyle | Frailty | AgingUnited States
-
Mersin UniversityCompleted
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRIActive, not recruiting
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRICompleted
-
Resverlogix CorpNot yet recruiting
-
Fengmei LianGuang'anmen Hospital of China Academy of Chinese Medical Sciences; Hubei Hospital... and other collaboratorsUnknownType2 Diabetes | Diabetic Non-proliferative Retinopathy
-
LEO PharmaCompletedAtopic DermatitisUnited States, Belgium, Canada, Australia, France, Germany, Japan, Netherlands, Poland, United Kingdom